E. Moretti

Heptadecanoylcarnitine (C17) a novel candidate biomarker for propionic and methylmalonic acidemias during expanded newborn screening

L. Grisotto, R. Guerrini, D. Chace, 2017 .

Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias.

Kathleen S. McGreevy, A. Biggeri, L. Grisotto, 2015, Clinica chimica acta; international journal of clinical chemistry.

Designing Soluble PROTACs: Strategies and Preliminary Guidelines

G. Caron, G. Ermondi, Daniela Pizzirani, 2022, Journal of medicinal chemistry.

CHF6001 II: A Novel Phosphodiesterase 4 Inhibitor, Suitable for Topical Pulmonary Administration—In Vivo Preclinical Pharmacology Profile Defines a Potent Anti-Inflammatory Compound with a Wide Therapeutic Window

A. Sala, S. Catinella, Valentina Bagnacani, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.

S. Catinella, L. Venturi, P. Puccini, 2022, Journal of medicinal chemistry.

Identification, Separation and Characterisation of Two Forms of Cytosolic 5′-Nucleotidase/Nucleoside Phosphotransferase in Calf Thymus

C. Baiocchi, F. Sgarrella, R. Pesi, 1998, Biological chemistry.

Identification of Multiple forms of the Cytosolic 5′-Nucleotidase/Phosphotransferase in Rat Tissues

C. Baiocchi, R. Pesi, M. Camici, 1998 .

New Ligandless C−H Activation Procedure for The Decoration of C‐3 Position of 1H‐Indazole Derivatives

L. Venturi, Sara Guariento, F. Bellina, 2023, ChemistrySelect.